Skip to content
2000
Volume 13, Issue 19
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

New compounds having affinity to various melanocortin receptors have recently been identified as possible neuroprotective agents. This review is focused on the role of neuroprotective effects of melanocortins in CNS injury and repair mechanisms. Using selective non-peptidic compounds with varying affinity to melanocortin receptors, our laboratory has shown their anti-edematous effects in the spinal cord injury. This effect of the compounds is related with their ability to attenuate blood-spinal cord barrier permeability. The functional significance and possible therapeutic strategies of these compounds in CNS injury are discussed.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161207781039797
2007-07-01
2025-04-21
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161207781039797
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test